• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钴胺素C缺乏症患者的治疗结果:单中心经验

Outcomes of patients with cobalamin C deficiency: A single center experience.

作者信息

Bourque Danielle K, Mellin-Sanchez Lizbeth E, Bullivant Garrett, Cruz Vivian, Feigenbaum Anette, Hewson Stacy, Raiman Julian, Schulze Andreas, Siriwardena Komudi, Mercimek-Andrews Saadet

机构信息

Division of Clinical and Metabolic Genetics, Department of Pediatrics The Hospital for Sick Children Toronto Ontario Canada.

Department of Pediatrics University of Toronto Toronto Ontario Canada.

出版信息

JIMD Rep. 2020 Nov 8;57(1):102-114. doi: 10.1002/jmd2.12179. eCollection 2021 Jan.

DOI:10.1002/jmd2.12179
PMID:33473346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7802631/
Abstract

Biallelic variants in results in the combined methylmalonic aciduria and homocystinuria, called cobalamin (cbl) C (cblC) deficiency. We report 26 patients with cblC deficiency with their phenotypes, genotypes, biochemical parameters, and treatment outcomes, who were diagnosed and treated at our center. We divided all cblC patients into two groups: group 1: SX group: identified after manifestations of symptoms (n = 11) and group 2: NB group: identified during the asymptomatic period via newborn screening (NBS) or positive family history of cblC deficiency (n = 15). All patients in the SX group had global developmental delay and/or cognitive dysfunction at the time of the diagnosis and at the last assessment. Seizure, stroke, retinopathy, anemia, cerebral atrophy, and thin corpus callosum in brain magnetic resonance imaging (MRI) were common in patients in the SX group. Global developmental delay and cognitive dysfunction was present in nine patients in the NB group at the last assessment. Retinopathy, anemia, and cerebral atrophy and thin corpus callosum in brain MRI were less frequent. We report favorable outcomes in patients identified in the neonatal period and treated pre-symptomatically. Identification of cblC deficiency by NBS is crucial to improve neurodevelopmental outcomes.

摘要

双等位基因变异会导致合并甲基丙二酸尿症和高胱氨酸尿症,即钴胺素(cbl)C(cblC)缺乏症。我们报告了26例在本中心诊断和治疗的cblC缺乏症患者,包括他们的表型、基因型、生化参数和治疗结果。我们将所有cblC患者分为两组:第1组:症状出现后确诊组(SX组):11例;第2组:无症状期确诊组(NB组):通过新生儿筛查(NBS)或cblC缺乏症家族史阳性在无症状期确诊,共15例。SX组所有患者在诊断时和最后一次评估时均有全面发育迟缓及/或认知功能障碍。SX组患者常见癫痫、中风、视网膜病变、贫血、脑萎缩以及脑磁共振成像(MRI)显示胼胝体变薄。在最后一次评估时,NB组有9例患者存在全面发育迟缓和认知功能障碍。视网膜病变、贫血以及脑MRI显示脑萎缩和胼胝体变薄的情况较少见。我们报告了新生儿期确诊并在症状出现前接受治疗的患者取得了良好的治疗效果。通过NBS识别cblC缺乏症对于改善神经发育结局至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/7802631/c5ae6d3efa1a/JMD2-57-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/7802631/c5ae6d3efa1a/JMD2-57-102-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e19/7802631/c5ae6d3efa1a/JMD2-57-102-g001.jpg

相似文献

1
Outcomes of patients with cobalamin C deficiency: A single center experience.钴胺素C缺乏症患者的治疗结果:单中心经验
JIMD Rep. 2020 Nov 8;57(1):102-114. doi: 10.1002/jmd2.12179. eCollection 2021 Jan.
2
Variable phenotypes and outcomes associated with the MMACHC c.482G > A mutation: follow-up in a large CblC disease cohort.与 MMACHC c.482G>A 突变相关的可变表型和结局:在一个大型 CblC 疾病队列中的随访。
World J Pediatr. 2024 Aug;20(8):848-858. doi: 10.1007/s12519-023-00770-2. Epub 2023 Dec 9.
3
Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type.神经和神经发育表型在早期治疗的合并甲基丙二酸血症和同型胱氨酸尿症、钴胺素 C 型的幼儿中。
Mol Genet Metab. 2013 Nov;110(3):241-7. doi: 10.1016/j.ymgme.2013.07.018. Epub 2013 Jul 25.
4
Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.与 MMACHC c.609G>A 同源突变相关的可变表型和结局:大型病例队列的长期随访。
Orphanet J Rare Dis. 2020 Aug 3;15(1):200. doi: 10.1186/s13023-020-01485-7.
5
Newborn screening and early biochemical follow-up in combined methylmalonic aciduria and homocystinuria, cblC type, and utility of methionine as a secondary screening analyte.联合型甲基丙二酸血症合并同型胱氨酸尿症 cblC 型的新生儿筛查和早期生化随访,以及蛋氨酸作为二级筛查分析物的应用。
Mol Genet Metab. 2010 Feb;99(2):116-23. doi: 10.1016/j.ymgme.2009.09.008. Epub 2009 Sep 27.
6
A clinical and gene analysis of late-onset combined methylmalonic aciduria and homocystinuria, cblC type, in China.中国迟发性甲基丙二酸血症合并同型胱氨酸尿症 cblC 型的临床和基因分析。
J Neurol Sci. 2012 Jul 15;318(1-2):155-9. doi: 10.1016/j.jns.2012.04.012. Epub 2012 May 4.
7
Spectrum of ocular manifestations in cobalamin C and cobalamin A types of methylmalonic acidemia.钴胺素C型和钴胺素A型甲基丙二酸血症的眼部表现谱
Ophthalmic Genet. 2016 Dec;37(4):404-414. doi: 10.3109/13816810.2015.1121500. Epub 2016 Mar 15.
8
PRDX1 gene-related epi-cblC disease is a common type of inborn error of cobalamin metabolism with mono- or bi-allelic MMACHC epimutations.PRDX1 基因相关的 epi-cblC 病是一种常见的钴胺素代谢先天性错误类型,具有单等位基因或双等位基因 MMACHC 外显子突变。
Clin Epigenetics. 2021 Jul 2;13(1):137. doi: 10.1186/s13148-021-01117-2.
9
Genetic analysis of four cases of methylmalonic aciduria and homocystinuria, cblC type#.4例cblC型甲基丙二酸尿症和高胱氨酸尿症的基因分析
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9337-41. eCollection 2015.
10
Prenatal diagnosis using genetic sequencing and identification of a novel mutation in MMACHC.利用基因测序进行产前诊断并鉴定MMACHC中的一种新突变。
BMC Med Genet. 2015 Jul 7;16:48. doi: 10.1186/s12881-015-0196-8.

引用本文的文献

1
Retinal Changes in Early-Onset cblC Methylmalonic Acidemia Identified Through Expanded Newborn Screening: Highlights from a Case Study and Literature Review.通过扩大新生儿筛查发现的早发型cblC型甲基丙二酸血症的视网膜变化:一项病例研究和文献综述的要点
Genes (Basel). 2025 May 25;16(6):635. doi: 10.3390/genes16060635.
2
Disorder of intracellular cobalamin metabolism: Importance of rapid diagnostic illustrated by a case report of early-onset methylmalonic aciduria and homocystinuria, cobalamin C type.细胞内钴胺素代谢紊乱:以早发型甲基丙二酸尿症和同型胱氨酸尿症(钴胺素C型)病例报告说明快速诊断的重要性。
Heliyon. 2025 Jan 23;11(3):e42086. doi: 10.1016/j.heliyon.2025.e42086. eCollection 2025 Feb 15.
3

本文引用的文献

1
Variable phenotypes and outcomes associated with the MMACHC c.609G>A homologous mutation: long term follow-up in a large cohort of cases.与 MMACHC c.609G>A 同源突变相关的可变表型和结局:大型病例队列的长期随访。
Orphanet J Rare Dis. 2020 Aug 3;15(1):200. doi: 10.1186/s13023-020-01485-7.
2
Early neurodevelopmental characterization in children with cobalamin C/defect.钴胺素 C/缺陷儿童的早期神经发育特征。
J Inherit Metab Dis. 2020 Mar;43(2):367-374. doi: 10.1002/jimd.12171. Epub 2020 Jan 16.
3
Mutation spectrum of MMACHC in Chinese pediatric patients with cobalamin C disease: A case series and literature review.
Late-onset cobalamin C deficiency type in adult with cognitive and behavioral disturbances and significant cortical atrophy and cerebellar damage in the MRI: a case report.
成人迟发性钴胺素C缺乏症伴认知和行为障碍及MRI显示显著皮质萎缩和小脑损伤:一例报告
Front Neurol. 2023 Dec 12;14:1308289. doi: 10.3389/fneur.2023.1308289. eCollection 2023.
4
Versatile enzymology and heterogeneous phenotypes in cobalamin complementation type C disease.钴胺素C型疾病中的多功能酶学与异质性表型
iScience. 2022 Aug 18;25(9):104981. doi: 10.1016/j.isci.2022.104981. eCollection 2022 Sep 16.
5
Screening for Methylmalonic and Propionic Acidemia: Clinical Outcomes and Follow-Up Recommendations.甲基丙二酸血症和丙酸血症的筛查:临床结局与随访建议
Int J Neonatal Screen. 2022 Feb 7;8(1):13. doi: 10.3390/ijns8010013.
6
Post-Treatment Movement Disorder in a Child with Late-onset Cobalamin Deficiency.一名迟发性钴胺素缺乏症儿童的治疗后运动障碍
Mov Disord Clin Pract. 2021 Dec 27;9(2):245-248. doi: 10.1002/mdc3.13387. eCollection 2022 Feb.
7
Ocular manifestations in patients with inborn errors of intracellular cobalamin metabolism: a systematic review.细胞内钴胺素代谢先天性错误患者的眼部表现:系统评价。
Hum Genet. 2022 Jul;141(7):1239-1251. doi: 10.1007/s00439-021-02350-8. Epub 2021 Oct 15.
中国儿童钴胺素C病患者中MMACHC的突变谱:病例系列及文献综述
Eur J Med Genet. 2019 Oct;62(10):103713. doi: 10.1016/j.ejmg.2019.103713. Epub 2019 Jul 4.
4
Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry.钴胺素依赖型再甲基化障碍和 MTHFR 缺陷的表型、治疗实践和结局:来自 E-HOD 登记处的数据。
J Inherit Metab Dis. 2019 Mar;42(2):333-352. doi: 10.1002/jimd.12041. Epub 2019 Feb 17.
5
Molecular genetic characterization of cblC defects in 126 pedigrees and prenatal genetic diagnosis of pedigrees with combined methylmalonic aciduria and homocystinuria.126个家系中cblC缺陷的分子遗传学特征及甲基丙二酸血症合并同型胱氨酸尿症家系的产前基因诊断
BMC Med Genet. 2018 Aug 29;19(1):154. doi: 10.1186/s12881-018-0666-x.
6
Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: a 16-year experience.新生儿筛查确诊的钴胺素C病患者早期治疗的疗效:16年经验
Genet Med. 2017 Aug;19(8):926-935. doi: 10.1038/gim.2016.214. Epub 2017 Feb 2.
7
Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency.钴胺素相关再甲基化障碍(cblC、cblD、cblE、cblF、cblG、cblJ和亚甲基四氢叶酸还原酶缺乏症)的诊断与管理指南
J Inherit Metab Dis. 2017 Jan;40(1):21-48. doi: 10.1007/s10545-016-9991-4. Epub 2016 Nov 30.
8
Ophthalmic Manifestations and Long-Term Visual Outcomes in Patients with Cobalamin C Deficiency.钴胺素C缺乏症患者的眼部表现及长期视觉预后
Ophthalmology. 2016 Mar;123(3):571-82. doi: 10.1016/j.ophtha.2015.10.041. Epub 2016 Jan 26.
9
Nephrotic syndrome and thrombotic microangiopathy caused by cobalamin C deficiency.钴胺素C缺乏所致肾病综合征和血栓性微血管病
Pediatr Nephrol. 2015 Jul;30(7):1203-6. doi: 10.1007/s00467-015-3110-x. Epub 2015 Apr 18.
10
Cobalamin C Disease Missed by Newborn Screening in a Patient with Low Carnitine Level.肉碱水平低的患者中新生儿筛查漏诊的钴胺素C病
JIMD Rep. 2015;23:71-5. doi: 10.1007/8904_2015_429. Epub 2015 Mar 13.